Previous study showed SR9009 could induce the apoptosis of cancer cells by suppressing autophagy and de novo lipogenesis through repressing fatty acid synthase (FAS) and stearoyl‐CoA desaturase 1 (SCD1) (Sulli et al., 2018). This evidence concerns the gene FASN and cancer.